Area of research
Cardiology and Cardiovascular Medicine
Research interest
Research interests include Cardiac pacing and defibrillation studies, Cardiac Arrhythmias and Treatments, Cardiac electrophysiology and arrhythmias, and Atrial Fibrillation Management and Outcomes.
Telemonitoring for heart failure: a meta-analysis.
Ability to remotely monitor atrial high-rate episodes using a single-chamber implantable cardioverter-defibrillator with a floating atrial sensing dipole.
Long-term safety and efficacy of renal sympathetic denervation in atrial fibrillation: 3-year results of the AFFORD study.
Practical considerations, indications, and future perspectives for leadless and extravascular cardiac implantable electronic devices: a position paper by EHRA/HRS/LAHRS/APHRS
Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study.
Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
Remote Monitoring of Heart Failure in Patients with Implantable Cardioverter-Defibrillators: Current Status and Future Needs.
Reassessment of clinical variables in cardiac resynchronization defibrillator patients at the time of first replacement: Death after replacement of CRT (DARC) score.
The value of remote care in the reduction of healthcare utilization in implantable cardioverter-defibrillator patients.
Quality of life, depression, and anxiety in patients with a subcutaneous versus transvenous defibrillator system.
Patient-Reported Quality of Life as a Predictor of Mortality and Ventricular Tachyarrhythmia's During 7 Years' Follow-Up in Patients With an Implantable Cardioverter Defibrillator (from the MIDAS Study).
Predicting defibrillator benefit in patients with cardiac resynchronization therapy: A competing risk study.
Evaluation of recurrent ventricular tachyarrhythmias in patients who survived out-of-hospital cardiac arrest due to ventricular fibrillation: eligibility for subcutaneous implantable defibrillator therapy.
Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts
Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication
Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator
Validation of the 2014 European Society of Cardiology Guidelines Risk Prediction Model for the Primary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
The learning curve associated with the introduction of the subcutaneous implantable defibrillator
Infection and mortality after implantation of a subcutaneous ICD after transvenous ICD extraction
Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry
Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator
Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: Patient outcomes, rate of appropriate and inappropriate interventions, and complications
Remote monitoring and follow-up of cardiovascular implantable electronic devices in the Netherlands